Trademarks / Class 42 / FIVEPRÍME PROTEIN MEDICINES FOR LIFE

FIVEPRÍME PROTEIN MEDICINES FOR LIFE

SN 85019223 REG 4455289Principal RegisterUSPTO TSDR ↗
Dead · Cancelled DEAD/REGISTRATION/Cancelled/Invalidated
Mark · Service Mark
FIVEPRÍME PROTEIN MEDICINES FOR LIFE - official mark drawing from the USPTO record

What this record means

The record shows that the mark “FIVEPRÍME PROTEIN MEDICINES FOR LIFE” was registered on the Principal Register on December 24, 2013 and is now cancelled under Section 8 because the owner, Five Prime Therapeutics, Inc., failed to file a required declaration. The mark covers scientific and technology services in class 042, specifically research and development services for protein therapeutics, prophylactics, diagnostics, and theranostics for treating, preventing, and diagnosing diseases. A similar name would raise the closest concern in that same class of scientific and technology services. The record does not give the owner control over every use of the wording, only over the specified services. No enforcement activity such as oppositions or cancellations appears in the supplied history. The latest meaningful event is the cancellation on July 31, 2020. For someone considering a similar name, the cancelled status reduces the risk of infringement in the listed services, but the mark’s prior registration still signals that the owner once claimed rights in that specific area.

Informational only - not legal advice.

Mark Service Mark

FIVEPRÍME PROTEIN MEDICINES FOR LIFE
Design mark - official drawing on the federal record · USPTO TSDR, retrieved Aug 28, 2026
Drawing type3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S) /NUMBER(S)
Filing basisUse in Commerce (§1(a)).
StatusRegistration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.

Key dates

Application filedApr 21, 2010
Published for oppositionSep 28, 2010
Notice of AllowanceNov 23, 2010
Registered (Principal)Dec 24, 2013
Status dateJul 31, 2020

Goods & services

Cl. 042Scientific & Technology ServicesSECTION 8 - CANCELLED

Research and development services for discovery and development of protein therapeutics, prophylactics, diagnostics, and theranostics for the treatment, prevention, palliation, and diagnosis of diseases

First use: Oct 19, 2006
Use in commerce: Oct 19, 2006

Owner & representation

OwnerFive Prime Therapeutics, Inc.
Address111 Oyster Point Boulevard, South San Francisco, CALIFORNIA UNITED STATES 94080
EntityCORPORATION - organized in DELAWARE
Attorney of recordLisa Greenwald-Swire
CorrespondentLisa Greenwald-Swire
Attorney emailt********@*****.com
Correspondent emailt********@*****.com
Correspondent phone6********0
Correspondent addressMinneapolis, MINNESOTA
Full details in the report

Prosecution history 3 of 50 events

Jul 31, 2020
CANCELLED SEC. 8 (6-YR)
Dec 24, 2018
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 24, 2018
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
🔒 Full timeline (50 events) in the report

Ask about this record ✦ AI

Your name deserves a straight answer.

Search the federal register free. No account, no caps, no waiting around.

Run a free trademark search